Nearly 800 Drugs are in Development for Rare Diseases, Most for Genetic Disorders, Says PhRMA

There are almost 800 drugs for rare diseases either in clinical trials or awaiting review by the FDA, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Source: Drug Industry Daily